<?xml version="1.0" encoding="UTF-8"?>
<ref id="B119-viruses-12-00339">
 <label>119.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grossardt</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Engeland</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Bossow</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Halama</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Zaoui</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Leber</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Springfeld</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Jaeger</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>von Kalle</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ungerechts</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine</article-title>
  <source>Hum. Gene Ther.</source>
  <year>2013</year>
  <volume>24</volume>
  <fpage>644</fpage>
  <lpage>654</lpage>
  <pub-id pub-id-type="doi">10.1089/hum.2012.205</pub-id>
  <?supplied-pmid 23642239?>
  <pub-id pub-id-type="pmid">23642239</pub-id>
 </element-citation>
</ref>
